1. Membrane Transporter/Ion Channel
  2. GLUT URAT1
  3. URAT1/GLUT9-IN-1

URAT1/GLUT9-IN-1 (compound 29) 能抑制尿酸转运蛋白1 (URAT1) (IC50=2.01 μM) 和葡萄糖转运蛋白9 (GLUT9) (IC50=18.21 μM)。 URAT1/GLUT9-IN-1 具有良好的药代动力学特性和口服生物利用度。 URAT1/GLUT9-IN-1 可用于痛风和高尿酸血症的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

URAT1/GLUT9-IN-1 Chemical Structure

URAT1/GLUT9-IN-1 Chemical Structure

CAS No. : 2883011-18-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 GLUT 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

URAT1/GLUT9-IN-1 (compound 29) can inhibit both uric acid transporter 1 (URAT1) (IC50=2.01 μM) and glucose transporter 9 (GLUT9) (IC50=18.21 μM). URAT1/GLUT9-IN-1 exhibits favorable pharmacokinetic properties and oral bioavailability. URAT1/GLUT9-IN-1 can be uesd for gout and hyperuricemia research[1].

IC50 & Target[1]

GLUT9

18.21 μM (IC50)

体外研究
(In Vitro)

URAT1/GLUT9-IN-1 对 urat1 介导的 14c-尿酸摄取具有最有效的抑制作用(IC50= 2.01 μM),是 Lesinurad(HY-15258)(IC50= 5.54 μM) 的 3 倍左右[1]
URAT1/GLUT9-IN-1 (5 μM) 对 GLUT9 的体外抑制活性略优于 Benzbromarone(HY-B1135), IC50 值为 18.21±1.03 μM[1]
URAT1/GLUT9-IN-1 (10 μM) 对 XOD 的抑制率小于 20%,表明其抑制作用可以忽略不计[1]
URAT1/GLUT9-IN-1 抑制 CYP(CYP2C9 (IC50= 2.00 μM) 和 CYP2C19 (IC50= 5.93 μM)) 药物代谢酶的抑制电位,表明具有较低的肝毒性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

URAT1/GLUT9-IN-1 (0.25,0.5,1mg/kg,po) 对急性高尿酸血症小鼠模型的降低 SUA 活性最小有效剂量约为 0.5 mg/kg [1]
URAT1/GLUT9-IN-1 (2mg/kg,po) 显示出作为降低 SUA 活性的候选药物的巨大潜力,与 Lesinurad (HY-15258) 相比,其效力高约 1.8 倍在稳定的高尿酸血症大鼠模型中[1]
URAT1/GLUT9-IN-1 (100 mg/kg,100 mg/kg,隔一天口服,为期 14 天) 较 Lesinurad (HY-15258) 组安全性显著提高在慢性高尿酸血症小鼠[1]
Pharmacokinetic Analysis in SD rats[1]

Route Dose (mg/kg) AUC0_t (ng•h/mL) AUC0_INF (ng•h/mL) MRT0_INF (h) T1/2 (h) Tmax (h) Cmax (ng/mL) Cl (L•h/kg) F (%)
p.o. 2 1813.4 7929.1 2.5 1.8 0.25 1272.7 / 20.1
i.v. 2 1903.7 1922.9 0.5 1.6 0.083 6591.8 17.5 /

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: stable hyperuricemia rat model
Dosage: 2 mg/kg
Administration: Oral gavage (p.o.)
Result: Had 90.12% titer ratio of decreasing sua activity.
Animal Model: 14-day model of chronic hyperuricemia
Dosage:
Administration: i.g.
Result: Exhibited superior therapeutic efficacy (76.33%) in chronic hyperuricemia in mice compared to lesinurad (33.56%)
Animal Model: Healthy Mice
Dosage: 100 mg/kg every other day for a period of 14 days
Administration: Oral gavage (p.o.)
Result: Caused slight weight loss and mild kidney damage.
分子量

435.56

Formula

C23H21N3O2S2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
URAT1/GLUT9-IN-1
目录号:
HY-158056
需求量: